Deerfield Management Company, L.P. (Series C) Blueprint Medicines Corp Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $5.95 Million - $12.1 Million	-110,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $7.1 Million - $8.74 Million	-75,354 Reduced 40.65%	110,000 $11.8 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $7.81 Million - $10.6 Million	-96,400 Reduced 34.21%	185,354 $19.1 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $6.02 Million - $7.35 Million	72,754 Added 34.81%	281,754 $24.8 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $17.8 Million - $21.3 Million	-196,386 Reduced 48.44%	209,000 $20.3 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $3 Million - $4.17 Million	-52,582 Reduced 11.48%	405,386 $31.6 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $5.15 Million - $8.79 Million	-106,946 Reduced 18.93%	457,968 $26.8 Million
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $12.5 Million - $15.5 Million	187,714 Added 49.77%	564,914 $45.3 Million
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $1.02 Million - $1.43 Million	-14,054 Reduced 3.59%	377,200 $27.7 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $8.5 Million - $11.3 Million	-115,611 Reduced 22.81%	391,254 $36.9 Million
Q1 2019 May 15, 2019	SELL	$48.7 - $86.6 $688,374 - $1.22 Million	-14,135 Reduced 2.71%	506,865 $40.6 Million
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $182,280 - $297,040	-4,000 Reduced 0.76%	521,000 $28.1 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $2.95 Million - $3.92 Million	50,050 Added 10.54%	525,000 $41 Million
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $5.85 Million - $9.71 Million	96,000 Added 25.33%	474,950 $30.2 Million
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $1.25 Million - $1.76 Million	-17,050 Reduced 4.31%	378,950 $34.8 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $12.1 Million - $17 Million	193,000 Added 95.07%	396,000 $29.9 Million
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $8.6 Million - $14.1 Million	203,000	203,000 $14.1 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account